argenX SE Announces AGM Voting Results

Ticker: ARGX · Form: 6-K · Filed: May 8, 2024 · CIK: 1697862

Sentiment: neutral

Topics: agm, voting-results, corporate-governance

TL;DR

argenX shareholders re-elected directors and approved 2023 accounts at the May 7th AGM.

AI Summary

On May 7, 2024, argenx SE announced the voting results from its Annual General Meeting of Shareholders held on May 7, 2024. Key resolutions included the reappointment of two directors, John R. H. Halstead and Dr. Pamela Marston-Schippers, for a term of four years each, and the approval of the annual accounts for the fiscal year ended December 31, 2023.

Why It Matters

This filing confirms shareholder confidence in the current board and financial reporting, which is crucial for maintaining investor trust and the company's stability.

Risk Assessment

Risk Level: low — The filing reports routine corporate governance matters and voting outcomes, which typically carry low risk.

Key Players & Entities

FAQ

Who were the directors reappointed at the May 7, 2024 Annual General Meeting?

John R. H. Halstead and Dr. Pamela Marston-Schippers were reappointed for a term of four years each.

What was the primary purpose of the May 7, 2024 press release?

The press release announced the voting results from argenx SE's Annual General Meeting of Shareholders.

What fiscal year's accounts were approved by shareholders?

The annual accounts for the fiscal year ended December 31, 2023, were approved.

When was the Annual General Meeting of Shareholders held?

The Annual General Meeting of Shareholders was held on May 7, 2024.

What is the filing type and date?

This is a Form 6-K filed on May 8, 2024, reporting on events for the month of May 2024.

Filing Stats: 306 words · 1 min read · ~1 pages · Grade level 13.8 · Accepted 2024-05-08 06:15:25

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ARGENX SE Date: May 8, 2024 By: /s/ Hemamalini (Malini) Moorthy Name: Hemamalini (Malini) Moorthy Title: General Counsel

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing